Resverlogix Corp. (TSE:RVX – Get Free Report) crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 47,615 shares changing hands.
Resverlogix Stock Up 5.3%
The stock has a market cap of C$31.70 million, a price-to-earnings ratio of -5.00 and a beta of 0.41. The business has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.10. The company has a debt-to-equity ratio of -83.11, a current ratio of 0.03 and a quick ratio of 0.04.
Resverlogix (TSE:RVX – Get Free Report) last posted its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share (EPS) for the quarter. On average, equities analysts predict that Resverlogix Corp. will post -0.22 earnings per share for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
